Helex: Valuation, Funding & Investors
Helex is a therapeutics company developing a new class of targeted medicines for genetic kidney diseases using its proprietary LNP drug delivery and AI-based drug design platforms. The company aims to create disease-modifying therapies for chronic and rare kidney disorders, addressing significant unmet medical needs.
Leadership & Board
- Current Number of Employees
- 37
- Current LinkedIn Followers
- 4,239
Latest Estimated Valuation
- Total Amount Raised
- $4M
- Total Funding Rounds
- 1
- Latest Funding Amount
- $4M
- Latest Funding Round
- Seed Round
Company Momentum
PositiveHelex LinkedIn following is increasing, signaling rising market interest, while its workforce is growing, indicating business expansion.
Employee Trend
Helex had 37 employees as of November 2, 2026. The number of employees increased by 0 (0.00%) week-over-week.
Social Trend
Helex had 4,239 followers as of November 2, 2026. The number of followers increased by 31 (0.74%) week-over-week.
Funding Round
| Funding Date | Funding Round | Amount Raised | Post-Money Valuation |
|---|---|---|---|
| Oct 30, 2025 | Seed Round | $3.50M | ― |
Investors
| Investor Name | Funding Round |
|---|---|
| SOSV | Seed Round |
| pi Ventures | Seed Round |
| Bluehill Capital | Seed Round |
Similar Companies
A snapshot of private companies similar to Helex, helping you discover and navigate related company profiles.
